S&P 500 Healthcare Sector SEC Filings — July 16, 2026
The 10 filings reveal a mixed Q2 2026 for S&P 500 Healthcare. Revenue growth is uneven: Intuitive Surgical posted 19% YoY growth driven by 16% procedure volume expansion, while UnitedHealth saw only 0.4% top-line growth but a 54% surge in operating earnings. Abbott raised full-year adjusted EPS guidance but reported declines in Nutrition (-3.6% comparable) and Rapid Diagnostics (-8.0%). Key headwinds include UnitedHealth's 525,000 sequential membership drop (driven by Medicare Advantage and Medicaid exits) and Intuitive’s estimated 1% revenue tariff impact. Insider activity is bearish: Moderna’s President sold $3.6M in stock, and Gilead’s CCO and CFO each sold ~$390K. Capital allocation is mixed: Intuitive repurchased $0.38B in shares, while UnitedHealth completed an acquisition. The overarching theme is a divide between MedTech growth and managed care margin recovery versus core weakness in diagnostics and membership attrition.